Khan and colleagues showed dozens of toll-like receptor genes to be changed after ischemia, and found that PACAP treatment could reverse these changes, as well as suppress the toll-like receptor-associated cytokine protein levels [81]. Here, ADCYAP1 is linked to ischemia.